Effects of clozapine and other atypical antipsychotics on infants development who were exposed to as fetus: A post-hoc analysis

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Shao, Ping ^a,b   Ou, Jianjun ^a   Peng, Mei ^a   Zhao, Jingping ^a   Chen, Jindong ^a   Wu, Renrong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Brain Hospital of Hunan Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; NEUROLEPTIC AGENT;

ADAPTIVE BEHAVIOR; ADULT; APGAR SCORE; ARTICLE; BAYLEY SCALES OF INFANT DEVELOPMENT; BIRTH WEIGHT; BODY HEIGHT; CHILD BEHAVIOR; CHILD DEVELOPMENT; COGNITION; CONTROLLED STUDY; DRUG EFFECT; EMOTIONALITY; FEMALE; FOLLOW UP; HUMAN; INFANT; LANGUAGE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PREGNANCY OUTCOME; PRENATAL EXPOSURE; SCHIZOPHRENIA; SCORING SYSTEM; SOCIAL ASPECT; ADVERSE EFFECTS; BODY WEIGHT; DRUG EFFECTS; MATERNAL EXPOSURE; NEWBORN; PREGNANCY; RISK FACTOR;

ADULT; ANTIPSYCHOTIC AGENTS; BODY HEIGHT; BODY WEIGHT; CHILD DEVELOPMENT; CLOZAPINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MATERNAL EXPOSURE; PREGNANCY; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS;

EID: 84929347171     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123373     Document Type: Article

References (21)

1. Lindenmayer JP, Liu-Seifert H, Kulkarni PM, Kinon BJ, Stauffer V, Edwards SE, et al. Medication non-adherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response. J Clin Psychiatry 2009; 70 (7): 990-996. doi: 10.4088/JCP.08m04221 PMID: 19497244
2. Wunderink L, Nienhuis FJ, Sytema S, Slooff CJ, Knegtering R, Wiersma D. Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome. J Clin Psychiatry 2007; 68(5):654-661. PMID: 17503973
3. Weiden PJ, Olfson M. Cost of relapse in schizophrenia. Schizophr Bull 1995; 21(3):419-429. PMID: 7481573
4. Hong J, Windmeijer F, Novick D, Haro JM, Brown J. The cost of relapse in patients with schizophrenia in the European SOHO (Schizophrenia Outpatient Health Outcomes) study. Prog Neuropsychopharmacol Biol Psychiatry 2009 (5); 33: 835-841. doi: 10.1016/j.pnpbp.2009.03.034 PMID: 19351551
5. Duran A, Ugur MM, Turan S, Emul M. Clozapine use in two women with schizophrenia during pregnancy. J Psychopharmacol 2008; 22(1):111-113. doi: 10.1177/0269881107079171 PMID: 18187538
6. Gupta N, Grover S. Safety of clozapine in 2 successive pregnancies. Can J Psychiatry 2004; 49 (12):863. PMID: 15679212
7. Lin HC, Chen IJ, Chen YH, Lee HC, Wu FJ. Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference? Schizophr Res 2010; 116(1): 55-60. doi: 10.1016/j.schres.2009.10.011 PMID: 19896335
8. Bayley N. Bayley Scales of Infant and Toddler Development, Third Edition. San Antonio, TX: Psychological Corporation; 2005.
9. First MB, Spitzer RL, Gibbon M: Structured Clinical Interview for DSM-IV Axis I Disorders- Clinician Version (SCID-CV). Washington, DC: American Psychiatry Press; 1997
10. th ed). Washington, DC: American Psychiatric Association; 1994
11. Gentile S. Infant safety with antipsychotic therapy in breast-feeding: a systematic review. J Clin Psychiatry 2008; 69(4):666-673. PMID: 18370569
12. McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O, et al. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry 2005; 66(4):444-49; quiz 546. PMID: 15816786
13. Mendhekar DN. Possible delayed speech acquisition with clozapine therapy during pregnancy and lactation. J Neuropsychiatry Clin Neurosci 2007; 19(2):196-197. PMID: 17431071
14. Msall ME. Measuring outcomes after extreme prematurity with the Bayley-III Scales of infant and toddler development: a cautionary tale from Australia. Arch Pediatr Adolesc Med 2010; 164(4):391-393. doi: 10.1001/archpediatrics.2010.25 PMID: 20368495
15. Robertson CM, Hendson L, Biggs WS, Acton BV. Application of the Flynn effect for the Bayley III Scales. Arch Pediatr Adolesc Med 2010; 164(11):1072-1073. doi: 10.1001/archpediatrics.2010.199 PMID: 21041604
16. Nguyen HN, Lalonde P. Clozapine and pregnancy. Encephale 2003; 29(2):119-124. PMID: 14567163
17. Gilad O, Merlob P, Stahl B, Klinger G. Outcome of infants exposed to olanzapine during breastfeeding. Breastfeed Med 2011; 6(2):55-58. doi: 10.1089/bfm.2010.0027 PMID: 21034242
18. Mucklow JC. The fate of drugs in pregnancy. Clin Obstet Gynaecol 1986; 13(2):161-175. PMID: 3731662
19. Anderson GD. Pregnancy-induced changes in pharmacokinetics: a mechanistic- based approach. Clin Pharmacokinet 2005; 44(10): 989-1008. PMID: 16176115
20. Newport DJ, Calamaras MR, DeVane CL, Donovan J, Beach AJ, Winn S, et al. Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry 2007; 164(8):1214-1220. PMID: 17671284
21. Peng M, Gao K, Ding Y, Ou J, Calabrese JR, Wu R, et al. Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study. Psychopharmacology (Berl). 2013 Aug; 228(4):577-84. doi: 10.1007/s00213-013-3060-6 PMID: 23559219